Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.

Publication ,  Journal Article
Subramaniam, RM; Truong, M; Peller, P; Sakai, O; Mercier, G
Published in: AJNR Am J Neuroradiol
April 2010

The hybrid technique of PET/CT has significantly impacted the imaging and management of HNSCC since its introduction in 2001 and has become the technique of choice for imaging of this cancer. Diagnostic FDG-PET/CT is useful for identification of an unknown primary tumor, delineation of extent of primary tumor, detection of regional lymph node involvement even in a normal-sized node, detection of distant metastases and occasional synchronous primary tumor, assessment of therapy response, and long-term surveillance for recurrence and metastases. The role of PET/CT is evolving in radiation therapy planning. Combined diagnostic PET/CT provides the best anatomic and metabolic in vivo information for the comprehensive management of HNSCC.

Duke Scholars

Published In

AJNR Am J Neuroradiol

DOI

EISSN

1936-959X

Publication Date

April 2010

Volume

31

Issue

4

Start / End Page

598 / 604

Location

United States

Related Subject Headings

  • Ultrasonography
  • Tumor Burden
  • Tomography, X-Ray Computed
  • Sensitivity and Specificity
  • Positron-Emission Tomography
  • Otorhinolaryngologic Neoplasms
  • Nuclear Medicine & Medical Imaging
  • Neoplasms, Unknown Primary
  • Neoplasms, Multiple Primary
  • Neoplasm, Residual
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Subramaniam, R. M., Truong, M., Peller, P., Sakai, O., & Mercier, G. (2010). Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. AJNR Am J Neuroradiol, 31(4), 598–604. https://doi.org/10.3174/ajnr.A1760
Subramaniam, R. M., M. Truong, P. Peller, O. Sakai, and G. Mercier. “Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.AJNR Am J Neuroradiol 31, no. 4 (April 2010): 598–604. https://doi.org/10.3174/ajnr.A1760.
Subramaniam RM, Truong M, Peller P, Sakai O, Mercier G. Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. AJNR Am J Neuroradiol. 2010 Apr;31(4):598–604.
Subramaniam, R. M., et al. “Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.AJNR Am J Neuroradiol, vol. 31, no. 4, Apr. 2010, pp. 598–604. Pubmed, doi:10.3174/ajnr.A1760.
Subramaniam RM, Truong M, Peller P, Sakai O, Mercier G. Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. AJNR Am J Neuroradiol. 2010 Apr;31(4):598–604.

Published In

AJNR Am J Neuroradiol

DOI

EISSN

1936-959X

Publication Date

April 2010

Volume

31

Issue

4

Start / End Page

598 / 604

Location

United States

Related Subject Headings

  • Ultrasonography
  • Tumor Burden
  • Tomography, X-Ray Computed
  • Sensitivity and Specificity
  • Positron-Emission Tomography
  • Otorhinolaryngologic Neoplasms
  • Nuclear Medicine & Medical Imaging
  • Neoplasms, Unknown Primary
  • Neoplasms, Multiple Primary
  • Neoplasm, Residual